Recombinant Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

  • Single User License $3500

Recombinant Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

Status : May, 2021 | Biotechnology

Report Digest


Global Recombinant Proteins Market: Overview

Rising incidences of chronic diseases, innovative recombinant products, augmented spending on research and development activities, and a growing preference for biosimilars and biologics are all contributing toward the expansion of the global recombinant protein market. Novel therapies for the purpose of treatment of serious chronic diseases such as cancer and other rare diseases are being developed utilizing recombinant proteins. The processing of recombinant proteins necessitates the use of a technique known as recombinant DNA (rDNA) technology. Proteins have been continuously developed as a crucial therapeutic choice in an extensive variety of human diseases as a result of various advancements made in the field of pharmaceutical processing and pharmacological understanding. Crohn's disease, rheumatoid arthritis, diabetes, anemia, dwarfism, and multiple sclerosis and many other diseases are treated with recombinant proteins.

On an average, across 27 OECD countries, nearly one-third of individuals aged 15 years and above reported suffering from two or more chronic diseases, including chronic respiratory problems, heart attack, stroke, diabetes, and cancer. This is according to the OECD's Health at a Glance, 2019 study. These chronic diseases are estimated to affect about one in every two people in Finland and Germany. Such high prevalence of chronic diseases are estimated to pave way for rapid growth of the global recombinant protein market in the years to come.

This study titled “global recombinant proteins market” comes with key market segments, namely product, application, end user, and regional markets. It also comes with an addition of evaluation of the prevailing competition in the global recombinant proteins market over the assessment timeline, from 2020 to 2030.

Global Recombinant Proteins Market: Key Trends

Due to approval cycles and long development times, the research and development sector has traditionally been capital-intensive. Research and development expenditures are a key element in global healthcare expenditure. Governments accept research and development as a critical component of a country's public benefit, international competitiveness, and growth. As a result, research and development spending and funding have steadily increased over time, which is estimated to augur well for the global recombinant proteins market in the near future.

In addition to that, there has been a strong emphasis on the advancement of recombinant protein-based therapies and vaccines for the treatment of Covid 19, which has been identified as a major burden on the global healthcare economy. For example, the Coalition for Epidemic Preparedness Innovations (CEPI) awarded Novavax, Inc US$ 4 Mn in October 2020 so as to accelerate the production of a Covid 19 vaccine based on its patented recombinant protein nanoparticle technology model.

However, since recombinant protein processing is basically a time-consuming process that also requires a high level of maintenance and cost, as well as safety and regulatory issues, the demand is expected to slow down during the projected timeline.

Global Recombinant Proteins Market: Competitive Assessment

In the global recombinant proteins market, top players are expected to compete aggressively. In this market, there are only a handful of renowned companies. China-based Elpiscience BioPharma and US-based Bio-Techne Corporation (US) entered into a partnership in 2020. Post partnership, Elpiscience is likely to gain access to Bio-vast Techne's product range of antibodies for utilization in the production of industrial, clinical, and preclinical biopharmaceuticals as part of this partnership, which seeks to develop anticancer therapeutics.

Some of the well-known players in the global recombinant proteins market are listed below:

  • Thermo Fisher Scientific, Inc.
  • GenScript Biotech Corporation
  • Enzo Life Sciences, Inc.
  • Sino Biological Inc.
  • StressMarq Biosciences Inc.
  • Bio-Rad Laboratories, Inc.

Global Recombinant Proteins Market: Regional Assessment

Because of rising research expenditures, as well as the presence of advanced healthcare infrastructure and many major market players, North America is expected to lead the global recombinant protein market over the analysis timeline, from 2020 to 2030.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?